Impact of surgical management of upper tract urothelial cancer in octogenarians: A population-based study

[1]  Yee Mun Lee,et al.  Optimal Management of Upper Tract Urothelial Carcinoma: Current Perspectives , 2020, OncoTargets and therapy.

[2]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[3]  B. Shuch,et al.  Survival outcomes for patients with localised upper tract urothelial carcinoma managed with non‐definitive treatment , 2018, BJU international.

[4]  M. Babjuk,et al.  European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update. , 2015, European urology.

[5]  N. Xu,et al.  Risk factors for bladder cancer recurrence survival in patients with upper-tract urothelial carcinoma , 2018, Tumori.

[6]  K. Nakagawa,et al.  The Conditional Survival with Time of Intravesical Recurrence of Upper Tract Urothelial Carcinoma , 2017, The Journal of urology.

[7]  K. Bensalah,et al.  Preoperative nomogram to predict the likelihood of complications after radical nephroureterectomy , 2017, BJU international.

[8]  Masafumi Nakamura,et al.  Risk factors for intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma , 2017, International Urology and Nephrology.

[9]  M. Babjuk,et al.  Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC) , 2017, World Journal of Urology.

[10]  M. Babjuk,et al.  Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel. , 2016, European urology.

[11]  Steven L. Chang,et al.  Upper tract urothelial carcinoma: a different disease entity in terms of management , 2016, ESMO Open.

[12]  R. Persad,et al.  Trends in incidence and survival for upper tract urothelial cancer (UTUC) in the state of Victoria – Australia , 2016, BJU international.

[13]  F. Montorsi,et al.  Conditional survival after radical nephroureterectomy for upper tract carcinoma. , 2015, European urology.

[14]  P. Colin,et al.  Risk-adapted strategy for the kidney-sparing management of upper tract tumours , 2015, Nature Reviews Urology.

[15]  M. Babjuk,et al.  European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update. , 2015, European urology.

[16]  J. Raman,et al.  Critical analysis of 30 day complications following radical nephroureterectomy for upper tract urothelial carcinoma. , 2014, The Canadian journal of urology.

[17]  A. Jemal,et al.  Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer , 2014, Cancer.

[18]  K. Bensalah,et al.  High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy. , 2014, Urologic oncology.

[19]  P. Grise,et al.  The efficacy of hemostatic radiotherapy for bladder cancer-related hematuria in patients unfit for surgery. , 2013, International braz j urol : official journal of the Brazilian Society of Urology.

[20]  J. Verne,et al.  Prognosis is deteriorating for upper tract urothelial cancer: data for England 1985–2010 , 2013, BJU international.

[21]  K. Bensalah,et al.  Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. , 2013, The Journal of urology.

[22]  A. Haider,et al.  Racial disparities in surgical care and outcomes in the United States: a comprehensive review of patient, provider, and systemic factors. , 2013, Journal of the American College of Surgeons.

[23]  V. Margulis,et al.  Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. , 2012, European urology.

[24]  J. Raman,et al.  Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973–2005 , 2011, BJU international.

[25]  A. Amodeo,et al.  Intractable haematuria: long‐term results after selective embolization of the internal iliac arteries , 2010, BJU international.

[26]  A. Finelli,et al.  Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. , 2009, Urology.

[27]  L. Lacombe,et al.  Carcinoma of the upper urinary tract , 2009, Cancer.

[28]  D. Bagley,et al.  What is the cost of maintaining a kidney in upper-tract transitional-cell carcinoma? An objective analysis of cost and survival. , 2009, Journal of endourology.

[29]  C. Wood,et al.  Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm? , 2006, BJU international.